medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2025, Number 3

<< Back Next >>

Rev Mex Urol 2025; 85 (3)

A scoping review about the early implantation of penile prosthesis in refractory ischemic priapism management

Uribe Bayona AJ, García-Perdomo HA

Language: English
References: 38
Page: 1-11
PDF size: 167.58 Kb.


ABSTRACT

Objective: To describe the state of the art on indications, complications, adverse effects, therapeutic options, and early vs. late insertion in patients with refractory priapism who underwent penile prosthesis implantation.
Methods: We searched MEDLINE (OVID), EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) from its inception to the present. Also, accessible clinical practice guidelines from North America, Europe, South Africa, and Japan.
Results: The search in the various research engines found 255 articles, of which 12 were chosen after eliminating duplicates, unrelated articles, and non-human studies.
Conclusion: The early use of penile prostheses is a viable option in the ischemic priapism refractory to first-line treatment, diminishing the risk of adverse events related to late implants and giving patients a possibility of preserving sexual function and, at the same time, providing therapy to an unusual pathology with significant comorbidity.


REFERENCES

  1. Montague DK, Jarow J, Broderick GA,Dmochowski RR, Heaton JPW, Lue TF, et al.American Urological Association guideline onthe management of priapism. The Journal ofUrology. 2003;170(4 Pt 1): 1318–1324. https://doi.org/10.1097/01.ju.0000087608.07371.ca.

  2. Broderick GA, Kadioglu A, Bivalacqua TJ,Ghanem H, Nehra A, Shamloul R. Priapism:pathogenesis, epidemiology, and management.The Journal of Sexual Medicine. 2010;7(1 Pt2): 476–500. https://doi.org/10.1111/j.1743-6109.2009.01625.x.

  3. Anele UA, Le BV, Resar LMS, Burnett AL.How I treat priapism. Blood. 2015;125(23):3551–3558. https://doi.org/10.1182/blood-2014-09-551887.

  4. Bivalacqua TJ, Allen BK, Brock GB, BroderickGA, Chou R, Kohler TS, et al. The Diagnosisand Management of Recurrent IschemicPriapism, Priapism in Sickle Cell Patients,and Non-Ischemic Priapism: An AUA/SMSNA Guideline. The Journal of Urology.2022;208(1): 43–52. https://doi.org/10.1097/JU.0000000000002767.

  5. Burnett AL. Pathophysiology of priapism:dysregulatory erection physiology thesis. TheJournal of Urology. 2003;170(1): 26–34. https://doi.org/10.1097/01.ju.0000046303.22757.f2.

  6. Arduini GAO, Trovó de Marqui AB. Prevalenceand Characteristics of Priapism in Sickle CellDisease. Hemoglobin. 2018;42(2): 73–77. https://doi.org/10.1080/03630269.2018.1452760.

  7. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL.New insights into the pathophysiology of sicklecell disease-associated priapism. The Journal ofSexual Medicine. 2012;9(1): 79–87. https://doi.org/10.1111/j.1743-6109.2011.02288.x.

  8. Mantadakis E, Cavender JD, Rogers ZR, EwaltDH, Buchanan GR. Prevalence of priapism inchildren and adolescents with sickle cell anemia.Journal of Pediatric Hematology/Oncology.1999;21(6): 518–522.

  9. Capece M, La Rocca R, Mirone V, Bivalacqua TJ,Castiglione F, Albersen M, et al. A SystematicReview on Ischemic Priapism and ImmediateImplantation: Do We Need More Data? SexualMedicine Reviews. 2019;7(3): 530–534. https://doi.org/10.1016/j.sxmr.2018.10.007.

  10. Muneer A, Macrae B, Krishnamoorthy S, ZumlaA. Urogenital tuberculosis - epidemiology,pathogenesis and clinical features. NatureReviews. Urology. 2019;16(10): 573–598.https://doi.org/10.1038/s41585-019-0228-9.

  11. Salonia A, Eardley I, Giuliano F, HatzichristouD, Moncada I, Vardi Y, et al. EuropeanAssociation of Urology guidelines on priapism.European Urology. 2014;65(2): 480–489.https://doi.org/10.1016/j.eururo.2013.11.008.

  12. Mishra K, Loeb A, Bukavina L, BaumgartenA, Beilan J, Mendez M, et al. Management ofPriapism: A Contemporary Review. SexualMedicine Reviews. 2020;8(1): 131–139. https://doi.org/10.1016/j.sxmr.2019.01.001.

  13. Tricco AC, Lillie E, Zarin W, O’Brien KK,Colquhoun H, Levac D, et al. PRISMAExtension for Scoping Reviews (PRISMA-ScR):Checklist and Explanation. Annals of InternalMedicine. 2018;169(7): 467–473. https://doi.org/10.7326/M18-0850.

  14. Sedigh O, Rolle L, Negro CLA, Ceruti C,Timpano M, Galletto E, et al. Early insertionof inflatable prosthesis for intractable ischemicpriapism: our experience and review of theliterature. International Journal of ImpotenceResearch. 2011;23(4): 158–164. https://doi.org/10.1038/ijir.2011.23.

  15. Zacharakis E, De Luca F, Raheem AA, GaraffaG, Christopher N, Muneer A, et al. Earlyinsertion of a malleable penile prosthesis inischaemic priapism allows later upsizing ofthe cylinders. Scandinavian Journal of Urology.2015;49(6): 468–471. https://doi.org/10.3109/21681805.2015.1059359.

  16. Ralph DJ, Garaffa G, Muneer A, FreemanA, Rees R, Christopher AN, et al. Theimmediate insertion of a penile prosthesisfor acute ischaemic priapism. EuropeanUrology. 2009;56(6): 1033–1038. https://doi.org/10.1016/j.eururo.2008.09.044.

  17. Salem EA, El Aasser O. Management of ischemicpriapism by penile prosthesis insertion:prevention of distal erosion. The Journal ofUrology. 2010;183(6): 2300–2303. https://doi.org/10.1016/j.juro.2010.02.014.

  18. Rees RW, Kalsi J, Minhas S, Peters J, KellP, Ralph DJ. The management of low-flowpriapism with the immediate insertion of apenile prosthesis. BJU international. 2002;90(9):893–897. https://doi.org/10.1046/j.1464-410x.2002.03058.x.

  19. Zacharakis E, Garaffa G, Raheem AA,Christopher AN, Muneer A, Ralph DJ.Penile prosthesis insertion in patients withrefractory ischaemic priapism: early vs delayedimplantation. BJU international. 2014;114(4):576–581. https://doi.org/10.1111/bju.12686.

  20. Durazi MH, Jalal AA. Penile prosthesisimplantation for treatment of postpriapismerectile dysfunction. Urology Journal. 2008;5(2):115–119.

  21. Mireku-Boateng A, Jackson AG. Penileprosthesis in the management of priapism.Urologia Internationalis. 1989;44(4): 247–248.https://doi.org/10.1159/000281515.

  22. Tausch TJ, Zhao LC, Morey AF, Siegel JA,Belsante MJ, Seideman CA, et al. Malleablepenile prosthesis is a cost-effective treatmentfor refractory ischemic priapism. The Journal ofSexual Medicine. 2015;12(3): 824–826. https://doi.org/10.1111/jsm.12803.

  23. Upadhyay J, Shekarriz B, Dhabuwala CB. Penileimplant for intractable priapism associatedwith sickle cell disease. Urology. 1998;51(4):638–639. https://doi.org/10.1016/s0090-4295(97)00704-8.

  24. Bella A, Wang R, Shamloul R, ZappavignaC, Ahmed M, Sadeghi-Nejad H. 1859 3-pieceinflatable penile prosthesis insertion postT-shunt for priapism with dilation/corporalsnake maneuver and comparison to post alghorabshunt ipp outcomes. The Journal ofUrology. 2012; https://doi.org/10.1016/j.juro.2012.02.1971.

  25. Monga M, Broderick GA, Hellstrom WJ.Priapism in sickle cell disease: the case forearly implantation of the penile prosthesis.European Urology. 1996;30(1): 54–59. https://doi.org/10.1159/000474145.

  26. Olujohungbe A, Burnett AL. How I managepriapism due to sickle cell disease. BritishJournal of Haematology. 2013;160(6): 754–765.https://doi.org/10.1111/bjh.12199.

  27. Govier FE, Jonsson E, Kramer-LevienD. Oral terbutaline for the treatment ofpriapism. The Journal of Urology. 1994;151(4):878–879. https://doi.org/10.1016/s0022-5347(17)35111-x.

  28. Zacharakis E, Raheem AA, Freeman A,Skolarikos A, Garaffa G, Christopher AN, etal. The efficacy of the T-shunt procedure andintracavernous tunneling (snake maneuver)for refractory ischemic priapism. The Journalof Urology. 2014;191(1): 164–168. https://doi.org/10.1016/j.juro.2013.07.034.

  29. Ortaç M, Çevik G, Akdere H, Ermeç B, KadıoğluA. Anatomic and Functional Outcome FollowingDistal Shunt and Tunneling for Treatmentİschemic Priapism: A Single-Center Experience.The Journal of Sexual Medicine. 2019;16(8):1290–1296. https://doi.org/10.1016/j.jsxm.2019.05.011.

  30. Bennett N, Mulhall J. Sickle cell disease statusand outcomes of African-American menpresenting with priapism. The Journal of SexualMedicine. 2008;5(5): 1244–1250. https://doi.org/10.1111/j.1743-6109.2008.00770.x.

  31. Kulmala RV, Lehtonen TA, Lindholm TS,Tammela TL. Permanent open shunt as areason for impotence or reduced potency aftersurgical treatment of priapism in 26 patients.International Journal of Impotence Research.1995;7(3): 175–180.

  32. Fuchs JS, Shakir N, McKibben MJ, MathurS, Teeple S, Scott JM, et al. PenoscrotalDecompression-Promising New TreatmentParadigm for Refractory Ischemic Priapism. TheJournal of Sexual Medicine. 2018;15(5): 797–802.https://doi.org/10.1016/j.jsxm.2018.02.010.

  33. Winter CC. Priapism cured by creation offistulas between glans penis and corporacavernosa. The Journal of Urology. 1978;119(2):227–228. https://doi.org/10.1016/s0022-5347(17)57440-6.

  34. Segal RL, Readal N, Pierorazio PM, BurnettAL, Bivalacqua TJ. Corporal Burnett ‘Snake’surgical maneuver for the treatment of ischemicpriapism: long-term followup. The Journal ofUrology. 2013;189(3): 1025–1029. https://doi.org/10.1016/j.juro.2012.08.245.

  35. Wilson SK, Zumbe J, Henry GD, Salem EA,Delk JR, Cleves MA. Infection reduction usingantibiotic-coated inflatable penile prosthesis.Urology. 2007;70(2): 337–340. https://doi.org/10.1016/j.urology.2007.03.058.

  36. Wilson SK. Reimplantation of inflatable penileprosthesis into scarred corporeal bodies.International Journal of Impotence Research.2003;15 Suppl 5: S125-128. https://doi.org/10.1038/sj.ijir.3901086.

  37. Bozkurt İH, Yonguç T, Aydoğdu Ö, DeğirmenciT, Arslan M, Minareci S. Use of a microdebriderfor corporeal excavation and penile prosthesisimplantation in men with severely fibrosedcorpora cavernosa: a new minimal invasivesurgical technique. Turkish Journal of Urology.2015;41(3): 119–124. https://doi.org/10.5152/tud.2015.36539.

  38. Tsambarlis PN, Chaus F, Levine LA. SuccessfulPlacement of Penile Prostheses in Men WithSevere Corporal Fibrosis Following VacuumTherapy Protocol. The Journal of Sexual Medicine.2017;14(1): 44–46. https://doi.org/10.1016/j.jsxm.2016.11.304.




2020     |     www.medigraphic.com